Connection Between CDC20 Expression and Hepatocellular Carcinoma Prognosis.

BACKGROUND Hepatocellular carcinoma (HCC) occurs frequently in China, with high morbidity and mortality. Cell division cycle 20 homolog (CDC20) is reportedly related to many cancers. In this study, we discuss a potential link of CDC20 expression to HCC patients' prognoses.

Acts as a Promising Novel Biomarker for the Prognosis of Patients with Hepatocellular Carcinoma.

Nuclear casein kinase and cyclin-dependent kinase substrate 1 () is highly expressed in some tumors, including hepatocellular carcinoma (HCC). However, its clinical significance in HCC prognosis is still unclear. The aim of this study was to explore the expression and prognostic value of in HCC.